In a statement made on Friday, the National Institute on Drug Abuse (NIDA) announced a “new requirement to measure and report results using a standard
The Bureau of International Narcotics and Law Enforcement at the State Department has gone on record stating that the United States could issue multiple licenses for
I received the following press release. Curious to see what Kevin Sabet has to say about this one: The results of an annual survey of
By Paul Armentano, NORML Deputy Director The director of the US National Institute on Drug Abuse (NIDA), Nora Volkow, believes that cannabidiol (CBD) – a
On Thursday, July 23rd Americans for Safe Access (ASA) is hosting a Congressional Briefing with Representative Earl Blumenauer (D-OR) on federal barriers faced by researchers
By Danielle Keane, NORML Political Director Members of the US Senate at a hearing yesterday expressed skepticism in regard to federal policies limiting the ability
At a hearing Wednesday, Sens. Cory Booker and Kirsten Gillibrand pressed federal officials to eliminate political barriers that are preventing research on the potential medical
On Monday, Politifact published the results of its research into the accuracy of MPP’s statement in a recent ad that marijuana is objectively safer than
Yesterday the National Institute on Drug Abuse released a statement denying that marijuana is less toxic than alcohol. How a federal agency can look at
Leading NIDA researcher Marilyn Huestis admits that there is “no direct correlation between driving impairment and THC concentration” and that “cannabis tolerance may develop in
How Will Mainstream Media Spin This Government Study? by Mitch Earleywine, Marijuana Policy Project The Rorschach Inkblot test asks people to make up stories about
Full replay of the entire press conference will be heard at 2pm and 5pm Pacific on https://radicalruss.com Representatives of law enforcement and drug rehabilitation services
The use of cannabis and cannabinoids likely mitigates symptoms associated with post-traumatic stress disorder (PTSD), according to a review of clinical and preclinical evidence published
By Steve Elliott of Toke of the Town On Friday, May 11, the U.S. Court of Appeals for the First Circuit in Boston will hear
This is a great opportunity to hear a guest speaker that is very, very unique: {Denver} — Irvin Rosenfeld is one of only 4 medical
